Prosperity Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,487
Closed -$208K 201
2024
Q1
$208K Sell
7,487
-167
-2% -$4.63K 0.1% 144
2023
Q4
$220K Buy
7,654
+57
+0.8% +$1.72K 0.14% 121
2023
Q3
$252K Buy
7,597
+615
+9% +$21.7K 0.16% 105
2023
Q2
$256K Buy
6,982
+132
+2% +$5.14K 0.17% 102
2023
Q1
$279K Buy
6,850
+2,466
+56% +$107K 0.22% 85
2022
Q4
$225K Buy
+4,384
New +$210K 0.21% 102

Other funds holding PFE

Prosperity Wealth Management's PFE Position: Q2 2024 in Review

Prosperity Wealth Management sold out of Pfizer (PFE) in Q2 2024, closing a stake of 7,487 shares — an estimated $208K sold.

Prosperity Wealth Management first reported a position in PFE in Q4 2022 and held it in 6 quarters. The position peaked at $279K in Q1 2023. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Prosperity Wealth Management reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Prosperity Wealth Management sold 7,487 Pfizer shares in Q2 2024, an estimated $208K.
  • Prosperity Wealth Management first reported a position in Pfizer in Q4 2022 and held it in 6 quarters.
  • Prosperity Wealth Management's Pfizer position peaked at $279K in Q1 2023.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Prosperity Wealth Management's 13F filing for Q2 2024, filed 14 Aug 2024.